Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Dementia in People with Type 2 Diabetes-A Population-Based Cohort Study

被引：0
|
作者：
Tang, Huilin
Shaaban, C. Elizabeth
Wu, Yonghui
Magoc, Tanja
Donahoo, William T.
Dekosky, Steven T.
Bian, Jiang
Guo, Jingchuan
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-894-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
894-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Heterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study
    Tang, Huilin
    Donahoo, William T.
    Svensson, Mikael
    Shaaban, C. Elizabeth
    Smith, Glenn
    Jaffee, Michael S.
    Huang, Yu
    Hu, Xia
    Lu, Ying
    Salloum, Ramzi G.
    Dekosky, Steven T.
    Bian, Jiang
    Guo, Jingchuan
    ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5528 - 5539
  • [2] SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS AND REDUCED RISK OF LIVER CANCER IN PEOPLE WITH TYPE 2 DIABETES: A POPULATION-BASED COHORT STUDY
    Huang, Pin-Chia
    Ma, Kevin Sheng-Kai
    HEPATOLOGY, 2023, 78 : S1925 - S1926
  • [3] Association of Sodium-Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
    Wu, Che-Yuan
    Iskander, Carina
    Wang, Christa
    Xiong, Lisa Y.
    Shah, Baiju R.
    Edwards, Jodi D.
    Kapral, Moira K.
    Herrmann, Nathan
    Lanctot, Krista L.
    Masellis, Mario
    Swartz, Richard H.
    Cogo-Moreira, Hugo
    MacIntosh, Bradley J.
    Rabin, Jennifer S.
    Black, Sandra E.
    Saskin, Refik
    Swardfager, Walter
    DIABETES CARE, 2023, 46 (02) : 297 - 304
  • [4] The use of sodium-glucose cotransporter 2 inhibitors and the incidence of uveitis in type 2 diabetes: a population-based cohort study
    Chung, Jui-Fu
    Yang, Po-Jen
    Chang, Chao-Kai
    Lee, Chia-Yi
    Huang, Jing-Yang
    Wang, Kai
    Yang, Shun-Fa
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (02) : 402 - 409
  • [5] Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
    Eroglu, Talip E.
    Coronel, Ruben
    Souverein, Patrick C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (04) : 289 - 295
  • [6] Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes A Population-Based Cohort Study
    Fralick, Michael
    Chen, Sarah K.
    Patorno, Elisabetta
    Kim, Seoyoung C.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (03) : 186 - +
  • [7] Sodium-glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population-based cohort study
    Aloe, Stephanie
    Filliter, Christopher
    Salmasi, Shahrzad
    Igweokpala, Samuel
    Yu, Oriana H. Y.
    Tagalakis, Vicky
    Filion, Kristian B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (09) : 2902 - 2914
  • [8] Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Dementia and Parkinson's disease among Patients with Type 2 Diabetes-A Longitudinal, Nationwide, Population-Based Cohort Study
    Kim, Hae Kyung
    Biessels, Geert J.
    Yu, Minheui
    Bae, Jihoon
    Choi, Arim
    Lee, Minyoung
    DIABETES, 2024, 73
  • [9] Sodium-glucose cotransporter-2 inhibitors and risk of hepatocellular carcinoma among patients with type 2 diabetes: A population-based cohort study
    Bea, Sungho
    Jeong, Han Eol
    Noh, Yunha
    Park, Sohee
    Sinn, Dong Hyun
    Kim, Jae Hyeon
    Yu, Oriana H. Y.
    Azoulay, Laurent
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 57 - 58
  • [10] Comment on 'sodium-glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population-based cohort study'
    Lai, Shih-Wei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (01) : 366 - 367
12345